⌘K

Home/Filings/4/0001104659-22-073634

4//SEC Filing

Manting Erik 4

Accession 0001104659-22-073634

CIK 0001829635other

View on SEC.gov Company Profile

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 8:24 PM ET

Size

5.4 KB

Accession

0001104659-22-073634

Insider Transaction Report

Form 4

Period: 2022-06-22

Transcode Therapeutics, Inc.RNAZ

Director

Transactions

Award
Stock Option (Right to Buy)
2022-06-22+9,500→ 9,500 total
Exercise: $1.24Exp: 2032-06-21→ Common Stock (9,500 underlying)

Footnotes (1)

[F1]The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 22, 2023 and (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time.

Documents

1 file

4
tm2219203-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Transcode Therapeutics, Inc.

CIK 0001829635

Entity typeother

Related Parties

1

filerCIK 0001856180

Filing Metadata

Form type: 4
Filed: Jun 21, 8:00 PM ET
Accepted: Jun 22, 8:24 PM ET
Size: 5.4 KB

View on SEC.gov